Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Midsize biotechs form coalition to fight against MFN policy
A group of 10 domestic, medium-sized biotechs launched the Midsized Biotech Alliance of America to advocate for free-market solutions to drug policy.
Will Maddox
Feb 25, 2026 1:05pm
China is no longer licensing 'bargain basement': analyst
Feb 24, 2026 5:07pm
Sponsored
iRegene Dual Firsts: US Dosing in PD Phase IIa, China MSA Enrollment
Feb 23, 2026 8:00am
Charles River sells CDMO and discovery assets in strategic pivot
Feb 25, 2026 1:54pm
ARPA-H designates up to $144M for anti-aging medical research
Feb 25, 2026 11:55am
After gene therapy exit, Pfizer licenses Beam gene editing asset
Feb 25, 2026 9:43am
More News
Fierce Biotech Fundraising Tracker '26: Breeze; Slate & more
Feb 25, 2026 8:00am
Novo Nordisk inks $2.1B oral drug delivery pact
Feb 25, 2026 8:00am
GSK pays $950M for Canadian biotech with Winrevair-like PAH drug
Feb 25, 2026 4:28am
Werewolf weighs sale or merger as cash reserves whimper
Feb 24, 2026 5:23pm
See more stories